Tibet AIM Pharm. Inc. (SHE:002826)
China flag China · Delayed Price · Currency is CNY
15.51
-0.48 (-3.00%)
Jul 30, 2026, 3:04 PM CST

Tibet AIM Pharm. Company Description

Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company’s products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; medicines for gynecology and obstetrics; and Gualoupi injection, Nalmefene hydrochloride injection, and Carbetocin injection.

It also provides Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems.

Tibet AIM Pharm. Inc. was founded in 2003 and is based in Lhasa, China.

Tibet AIM Pharm. Inc.
CountryChina
Founded2003
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees405
CEOZhou Min

Contact Details

Address:
No. 6, Linqionggang Road
Lhasa, 850000
China
Phone86 10 5873 1208
Websiteemyy.cn

Stock Details

Ticker Symbol002826
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100002C39
SIC Code2834

Key Executives

NamePosition
Zhou MinGM, Chief Financial Officer and Director
Qianjin LiDeputy GM and Secretary of the Board of Directors
Ying GaoDeputy General Manager
Huaming JiangDeputy General Manager
Yongxiang ZhangAccounting Supervisor
Lian YangDeputy General Manager
Jing Sheng CuiDeputy General Manager